• ZCL278: Selective Cdc42 Inhibitor Workflows

  2026-08-19

  ZCL278 is a selective Cdc42 inhibitor for connecting biochemical GTPase control with measurable changes in cell migration, neuronal morphology, and fibroblast behavior. This workflow-focused guide shows how to prepare the compound, build dose and time courses, pair motility assays with pathway readouts, and interpret findings alongside emerging Cdc42–β-catenin fibrosis biology.

• NU7441 (KU-57788) Workflow for DNA-PK Studies

  2026-08-19

  NU7441 (KU-57788) is a potent ATP-site DNA-PK inhibitor for dissecting DNA repair, chemosensitization, and cell-cycle responses. This practical guide connects validated oncology workflows with a carefully bounded assay strategy for studying cytosolic DNA and TDP-43 homeostasis.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit

  2026-08-18

  The HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit enables tunable fluorescent RNA probe synthesis for in situ hybridization and Northern blot workflows. This guide connects probe design with lessons from ROS-responsive mRNA delivery research while clarifying what fluorescence can—and cannot—prove.

• Latrunculin B as a Temporal Actin Perturbation Tool

  2026-08-18

  Latrunculin B is more than an actin polymerization inhibitor: its transient pharmacology can reveal whether a cellular process truly depends on filament assembly. This article connects molecular mechanism, assay timing, and the Wang et al. GCRV entry study to improve interpretation of cytoskeletal experiments.

• Pepstatin A: A Practical Aspartic Protease Workflow

  2026-08-17

  Pepstatin A is a versatile aspartic protease inhibitor for testing cathepsin D-dependent autophagy-lysosomal function, viral protein processing, and osteoclast biology. This workflow translates a recent ischemia/reperfusion study into practical assay design, dosing, controls, and troubleshooting decisions.

• Okadaic acid: PP1/PP2A Workflow Guide

  2026-08-17

  Okadaic acid (SKU A4540) provides concentration-dependent inhibition of PP2A and PP1 for testing phosphorylation-dependent signaling and apoptosis-related endpoints. It is appropriate for controlled biochemical and cell-based studies, but not for assigning pathway-specific causality without vehicle, selectivity, and orthogonal assay controls.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-16

  Wang et al. identify METTL16 as a ferroptosis suppressor in hepatocellular carcinoma and define a mechanistic METTL16–SENP3–LTF axis that links m6A-regulated RNA stability to iron handling. The findings connect elevated METTL16 and SENP3 with tumor progression and poor prognosis, while suggesting that this pathway may be explored to increase ferroptosis sensitivity in HCC.

• Oltipraz Workflows for Nrf2 and MASLD Research

  2026-08-15

  Use Oltipraz as a defined Nrf2 pathway perturbation tool to connect phase II enzyme induction with autophagy, ferroptosis, and liver-injury assays. This practical guide covers solvent handling, dose-finding, orthogonal readouts, and troubleshooting for chemoprevention and MASLD research.

• Trelagliptin Succinate and Adipocyte Insulin Resistance

  2026-08-14

  The reference study identifies a cellular mechanism by which trelagliptin succinate, also known as SYR-472 succinate, may improve insulin resistance in differentiated adipocytes. Its results connect PI-3K/AKT signaling, GLUT4 membrane translocation, glucose uptake, and adipokine regulation, while also defining important limits for translation beyond the cell model.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide

  2026-08-14

  Build customizable Cy5-labeled RNA probes for spatial transcript detection and Northern blot validation with a workflow that separates labeling efficiency from hybridization performance. This guide connects practical probe engineering to TREM2 macrophage research while emphasizing controls, optimization, and assay-specific troubleshooting.

• nor-NOHA: Arginase Workflows for Cancer Research

  2026-08-13

  Build controlled arginine-metabolism experiments with nor-NOHA acetate across HepG2, AML, immune-cell, and vascular models. This guide combines reversible target engagement with practical assay design, orthogonal readouts, and troubleshooting for apoptosis, invasion, immune suppression, and endothelial function studies.

• Turning SA-β-Gal Into a Translational Decision Tool

  2026-08-13

  A phenotype-first framework for using SA-β-Gal staining to validate senescence models, strengthen senolytic screening, and improve translational interpretation across cultured cells and frozen tissue sections.

• nor-NOHA and the Next Logic of Translational Research

  2026-08-12

  Arginine metabolism is more than a biochemical pathway: it is a strategic control point linking tumor behavior, nitric oxide biology, vascular function, and immune context. This thought-leadership analysis positions nor-NOHA acetate as a mechanistic research tool while defining what is established, what remains hypothetical, and how translational teams can build stronger validation programs.

• nor-NOHA Acetate Workflows for Cancer Research

  2026-08-12

  Build controlled arginase-inhibition experiments around nor-NOHA acetate, from HepG2 apoptosis and invasion assays to exploratory immune-metabolic studies in AML. The workflow emphasizes reversible pharmacology, solvent control, orthogonal readouts, and clear separation between established evidence and hypothesis-generating applications.

• Nadolol (SQ-11725) in PK Research

  2026-08-11

  Nadolol (SQ-11725) combines non-selective beta-adrenergic blockade with transporter-focused pharmacokinetic research utility. This practical guide shows how to build reproducible signaling, uptake, tissue-distribution, and exposure workflows for hypertension research, angina pectoris studies, and vascular headache research.

7312 records 2/488 page Previous Next 12345 下5页 Last page